Skip to main content
. Author manuscript; available in PMC: 2012 Aug 23.
Published in final edited form as: Prostate. 2011 Mar 22;71(15):1668–1679. doi: 10.1002/pros.21383

Fig. 6.

Fig. 6

CD44 is expressed in prostatic SCNC and PC3 cells but not in the luminal type tumor cells of prostatic adenocarcinoma and LNCaP cells. A: Immunohistochemical study shows positive staining in prostatic SCNC but not in adenocarcinoma (with the exception of rare NE tumor cells, arrow). The LNCaP xenograft tumor cells are negative for CD44 but the PC3 xenograft tumors are positive (IHC, 400×). B: qPCR study shows very low levels of CD44 mRNA in LNCaP cells but high levels in PC3 cells. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]